Accessibility Menu
Demant A/s logo

Demant A/s(OTC) WILYY

Market Cap$9.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2011)+147%
5 Year-19%
1 Year+18%
1 Month+9%
$23.00
+2.22%
+0.50Today
Demant A/s last closing stock price
MetricPriceDate
Last closeUSD 22.502026-08-13
Demant A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.88%USD 21.872026-08-06
1 month+8.91%USD 20.662026-07-14
3 month+24.65%USD 18.052026-05-15
Year to date+37.28%USD 16.392025-12-31
1 year+18.47%USD 18.992025-08-13
3 year+15.3%USD 19.522023-08-14
5 year-18.63%USD 27.652021-08-13
Since inception+147.39%USD 9.102011-07-01

Demant A/s Financials at a Glance

Market Cap

$9.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

DKK 47.56B

Net Income (TTM)

DKK 3.94B

EPS (TTM)

$0.60

P/E Ratio

37.38

Dividend

$0.00

Beta (Volatility)

0.32 (Low)

Price

$23.00

Volume

109

Open

$23.00

Previous Close

$22.50

Daily Range

$23.00 - $23.00

52-Week Range

$13.45 - $23.00

Estimated Earnings Date

May 27, 2026

WILYY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Demant A/s

Demant A/S is a leading hearing healthcare company operating globally, with a strong presence in Europe, North America, and Asia. The company specializes in the development, manufacture, and wholesale of hearing aids, as well as providing hearing care clinics and assessment solutions.

Products and Services
  • Hearing aids designed for various levels of hearing loss
  • Hearing care clinics offering personalized services
  • Assessment solutions for audiologists and ENT doctors
Growth Outlook
  • Revenue increased to DKK 11.73 billion in Q4 2025
  • Net income reached DKK 1.22 billion in Q4 2025
  • Strong demand for hearing aids supports future growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of DKK 45.5 billion
  • Operating income margin at 17.6% for Q4 2025
  • Net profit margin improved to 10.7% in Q4 2025
Demant A/S has established itself as a key player in the hearing healthcare sector, driven by innovation and a commitment to improving the quality of life for individuals with hearing loss. The company's diverse product offerings and global reach position it well for continued growth in a market that is increasingly recognizing the importance of hearing health. Recent financial performance indicates a robust demand for its products, with significant revenue and net income growth in the latest quarter. The strong operating income margin reflects effective cost management and operational efficiency, further enhancing the company's attractiveness to potential investors.
AI Generated • Jul 25, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

26,704

CEO

Søren Nielsen

Website

www.demant.com

Headquarters

Smorum, ZE 2765, DK

WILYY Financials

Key Financial Metrics (TTM)

Gross Margin

70.96%

Operating Margin

17.88%

Net Income Margin

6.51%

Return on Equity

15.31%

Return on Capital

12.68%

Return on Assets

4.03%

Earnings Yield

2.68%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

417.71M

Volume

109

Avg. Volume

170

Financials (TTM)

Gross Profit

DKK 36.21B

Operating Income

DKK 8.38B

EBITDA

DKK 11.98B

Operating Cash Flow

DKK 8.48B

Capital Expenditure

-DKK 1.43B

Free Cash Flow

DKK 7.05B

Cash & ST Invst.

DKK 1.50B

Total Debt

DKK 20.28B

Demant A/s Performance Analysis

Demant A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31DKK 2,755,207,491-3.0%
20232023-12-31DKK 3,149,613,38114.3%
20242024-12-31DKK 3,251,987,0343.3%
20252025-12-31DKK 3,489,941,1867.3%
Demant A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-312.2%
Q22025-06-30-0.7%
Q42025-12-314.2%
Q22026-06-3013.0%
Demant A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31DKK 0.65-23.5%
20232023-12-31DKK 0.58-10.3%
20242024-12-31DKK 0.8138.0%
20252025-12-31DKK 0.55-31.3%
Demant A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-23.6%
Q22025-06-3013.1%
Q42025-12-31-68.4%
Q22026-06-30240.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

DKK 13.25B

+19.5%

Gross Profit

DKK 10.23B

+20.2%

Gross Margin

77.23%

N/A

Market Cap

$9.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$351.95K

N/A

Employees

26,704

N/A

Net Income

DKK 1.21B

+1.0%

EBITDA

DKK 3.17B

+34.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

DKK 1.50B

+42.8%

Total Debt

DKK 20.28B

+28.2%

Accounts Receivable

DKK 5.26B

+41.8%

Inventory

DKK 2.81B

+5.0%

Long Term Debt

DKK 13.13B

-0.5%

Short Term Debt

DKK 7.16B

+171.8%

Return on Assets

4.03%

N/A

Return on Invested Capital

16.05%

N/A

Free Cash Flow

DKK 1.37B

+50.6%

Operating Cash Flow

DKK 1.64B

+36.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BDUUFBangkok Dusit Medical Services Public Company Limited
$0.64+0.00%
ESAIYEisai Co., Ltd.
$7.57-0.42%
ESALFEisai Co., Ltd.
$28.71+0.00%
SSMXYSysmex Corporation
$12.02+1.52%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.25+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64-0.00%
ONDSOndas
$9.16+0.03%
INTCIntel
$103.10-0.01%

Questions About WILYY

What is the current price of Demant A/s?

Demant A/s is trading at $23.00 per share.

What is the 52-week range for Demant A/s?

Over the past 52 weeks, Demant A/s has traded between $13.45 and $23.00.

How much debt does Demant A/s have?

As of the most recent reporting period, Demant A/s reported total debt of DKK 3.30B.

How much cash does Demant A/s have on hand?

Demant A/s reported DKK 209.13M in cash and cash equivalents in its most recent financial results.

What is Demant A/s’s dividend yield?

Demant A/s does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services